| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -453,0 € | -1.1% | -448,2 € | +14.3% | -523,2 € | -101.3% | 39,0 k € | +951.9% | -4,6 k € | -188.2% | 5,2 k € | +258.2% | -3,3 k € | -148.4% | 6,8 k € | +123.4% | -29,0 k € | -3935.8% | 756,0 € | +128.5% | -2,7 k € | -111.1% | 23,9 k € | +179.9% | -29,9 k € | -744.4% | -3,5 k € | +71.5% | -12,4 k € | -189.3% | -4,3 k € | -239.1% | -1,3 k € | |
| EBITDA | -597,1 € | -1.4% | -588,7 € | +10.1% | -654,9 € | -101.7% | 38,9 k € | +927.5% | -4,7 k € | -192.7% | 5,1 k € | +248.5% | -3,4 k € | -162.1% | 5,5 k € | +118.4% | -29,9 k € | -10634.9% | 283,5 € | +109.1% | -3,1 k € | -113.4% | 23,4 k € | +177.1% | -30,3 k € | -655.4% | -4,0 k € | +69.9% | -13,4 k € | -180.7% | -4,8 k € | -129.3% | -2,1 k € | |
| Operating profit | -597,1 € | -1.4% | -588,7 € | +10.1% | -654,9 € | -101.7% | 38,9 k € | +927.5% | -4,7 k € | -192.7% | 5,1 k € | +248.5% | -3,4 k € | -162.1% | 5,5 k € | +118.4% | -29,9 k € | -10634.9% | 283,5 € | +109.1% | -3,1 k € | -113.7% | 22,9 k € | +172.7% | -31,4 k € | -516.8% | -5,1 k € | +63.3% | -13,9 k € | -192.0% | -4,8 k € | -129.3% | -2,1 k € | |
| Profit/loss | -26,4 k € | -45.8% | -18,1 k € | +14.1% | -21,1 k € | -184.3% | 25,0 k € | +213.8% | -22,0 k € | -113.2% | -10,3 k € | +40.6% | -17,3 k € | -125.1% | -7,7 k € | +79.2% | -37,1 k € | -337.9% | -8,5 k € | +33.8% | -12,8 k € | -169.6% | 18,4 k € | +154.6% | -33,6 k € | -853.2% | -3,5 k € | +63.1% | -9,6 k € | -472.1% | -1,7 k € | -179.5% | 2,1 k € | |
| Equity | -120,4 k € | -28.1% | -94,0 k € | -23.8% | -75,9 k € | -38.4% | -54,9 k € | +31.3% | -79,9 k € | -37.9% | -57,9 k € | -21.6% | -47,6 k € | -57.3% | -30,3 k € | -34.1% | -22,6 k € | -255.8% | 14,5 k € | -36.9% | 22,9 k € | -35.8% | 35,7 k € | +105.7% | 17,4 k € | -66.0% | 51,0 k € | -6.5% | 54,5 k € | -12.6% | 62,4 k € | -2.6% | 64,1 k € | |
| Total assets | 398,9 k € | -0.1% | 399,5 k € | -0.1% | 400,0 k € | -0.2% | 400,8 k € | +10.7% | 362,2 k € | +4.3% | 347,3 k € | +1.4% | 342,6 k € | -1.0% | 346,0 k € | +0.8% | 343,2 k € | -1.0% | 346,7 k € | +25.1% | 277,2 k € | +45.4% | 190,7 k € | +123.8% | 85,2 k € | +39.7% | 61,0 k € | -5.9% | 64,8 k € | +3.3% | 62,8 k € | -2.1% | 64,1 k € | |
| Cash | 58,0 k € | -1.0% | 58,6 k € | -0.4% | 58,9 k € | +15.1% | 51,1 k € | +302.1% | 12,7 k € | +95.9% | 6,5 k € | +274.2% | 1,7 k € | -66.2% | 5,1 k € | +322.7% | 1,2 k € | -74.5% | 4,8 k € | +124.9% | 2,1 k € | -67.8% | 6,6 k € | -29.2% | 9,3 k € | -17.1% | 11,2 k € | +0.7% | 11,2 k € | — | 1,1 k € | |||
| Debts | 519,3 k € | +5.2% | 493,5 k € | +3.7% | 476,0 k € | +4.5% | 455,7 k € | +3.1% | 442,0 k € | +9.1% | 405,2 k € | +3.9% | 390,2 k € | +3.7% | 376,2 k € | +2.9% | 365,7 k € | +10.1% | 332,3 k € | +30.7% | 254,3 k € | +64.1% | 154,9 k € | +128.4% | 67,8 k € | +580.3% | 10,0 k € | -2.8% | 10,3 k € | +3109.3% | 319,7 € | — | ||
Public limited company · Gent · incorporated on 05/08/2008
Public limited company loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CRYOSTORAGE is a Public limited company incorporated in 2008. Its main activity is: Other human health activities. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette